|
Originally published In Press as doi:10.1074/jbc.M209683200 on March 10, 2003
J. Biol. Chem., Vol. 278, Issue 20, 18563-18572, May 16, 2003
Serp-1, a Viral Anti-inflammatory Serpin, Regulates
Cellular Serine Proteinase and Serpin Responses to Vascular Injury*
Erbin
Dai ,
Haiyan
Guan ,
Liying
Liu ,
Stephen
Little §,
Grant
McFadden¶,
Sepideh
Vaziri ,
Henian
Cao ,
Iordanka A.
Ivanova ,
Leila
Bocksch¶, and
Alexandra
Lucas §¶
From the Vascular Biology Research Group, John P. Robarts' Research Institute, the § Division of
Cardiology, London Health Sciences Center, University Hospital, and
the ¶ Department of Microbiology and Immunology, University of
Western Ontario, London, Ontario N6A 5K8, Canada
Complex DNA viruses have tapped into cellular
serpin responses that act as key regulatory steps in coagulation and
inflammatory cascades. Serp-1 is one such viral serpin that effectively
protects virus-infected tissues from host inflammatory responses. When given as purified protein, Serp-1 markedly inhibits vascular monocyte invasion and plaque growth in animal models. We have investigated mechanisms of viral serpin inhibition of vascular inflammatory responses. In vascular injury models, Serp-1 altered early cellular plasminogen activator (tissue plasminogen activator), inhibitor (PAI-1), and receptor (urokinase-type plasminogen activator) expression (p < 0.01). Serp-1, but not a reactive center loop
mutant, up-regulated PAI-1 serpin expression in human endothelial
cells. Treatment of endothelial cells with antibody to urokinase-type
plasminogen activator and vitronectin blocked Serp-1-induced changes.
Significantly, Serp-1 blocked intimal hyperplasia (p < 0.0001) after aortic allograft transplant (p < 0.0001) in PAI-1-deficient mice. Serp-1 also blocked plaque growth
after aortic isograft transplant and after wire-induced injury
(p < 0.05) in PAI-1-deficient mice indicating that
increase in PAI-1 expression is not required for Serp-1 to block
vasculopathy development. Serp-1 did not inhibit plaque growth in
uPAR-deficient mice after aortic allograft transplant. We conclude that
the poxviral serpin, Serp-1, attenuates vascular inflammatory responses
to injury through a pathway mediated by native uPA receptors and vitronectin.
*
This work was supported by research grants from the Heart
and Stroke Foundation of Ontario and the Canadian Institutes of Health
Research.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom all correspondence should be addressed: John P. Robarts' Research Institute, University of Western Ontario, 100 Perth Dr., P.O. Box 5015, London, Ontario N6A 5K8, Canada. Tel.: 519-685-8300 (ext. 34071); Fax: 519-663-3789; E-mail: arl@robarts.ca.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Viswanathan, J. Richardson, B. Togonu-Bickersteth, E. Dai, L. Liu, P. Vatsya, Y.-m. Sun, J. Yu, G. Munuswamy-Ramanujam, H. Baker, et al.
Myxoma viral serpin, Serp-1, inhibits human monocyte adhesion through regulation of actin-binding protein filamin B
J. Leukoc. Biol.,
March 1, 2009;
85(3):
418 - 426.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Dai, K. Viswanathan, Y. M. Sun, X. Li, L. Y. Liu, B. Togonu-Bickersteth, J. Richardson, C. Macaulay, P. Nash, P. Turner, et al.
Identification of Myxomaviral Serpin Reactive Site Loop Sequences That Regulate Innate Immune Responses
J. Biol. Chem.,
March 24, 2006;
281(12):
8041 - 8050.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Lucas and G. McFadden
Secreted Immunomodulatory Viral Proteins as Novel Biotherapeutics
J. Immunol.,
October 15, 2004;
173(8):
4765 - 4774.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Bot, J. H. von der Thusen, M. M.P.C. Donners, A. Lucas, M. L. Fekkes, S. C.A. de Jager, J. Kuiper, M. J.A.P. Daemen, T. J.C. van Berkel, S. Heeneman, et al.
Serine Protease Inhibitor Serp-1 Strongly Impairs Atherosclerotic Lesion Formation and Induces a Stable Plaque Phenotype in ApoE-/- Mice
Circ. Res.,
September 5, 2003;
93(5):
464 - 471.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|